Learning Objectives:

1. Recognize clinical features of STING-associated vasculopathy.

2. Explain the cGAS-STING pathway and its role in autoimmunity.

3. Explain the cGAS-STING pathway and its role in antiviral immunity.

 

Session date: 
03/10/2020 - 8:30am to 9:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Jonathan Miner, M.D., Ph.D.